No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
MEDP240719P430000
- 5.50
- -14.47-72.46%
15min DelayClose Jul 12 15:59 ET
5.50High5.50Low
5.50Open19.97Pre Close1 Volume1 Open Interest430.00Strike Price550.00Turnover49.51%IV4.18%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier5DDays to Expiry5.50Extrinsic Value100Contract SizeAmericanOptions Type-0.3025Delta0.0125Gamma79.82Leverage Ratio-0.8354Theta-0.0210Rho-24.14Eff Leverage0.1965Vega
Intraday
- 5D
- Daily
News
Medpace (MEDP) Beats Stock Market Upswing: What Investors Need to Know
Baird Adjusts Medpace Holdings' Price Target to $469 From $456, Keeps Outperform Rating
Medpace Holdings (MEDP) has an average rating of outperform and price targets ranging from $296 to $480, according to analysts polled by Capital IQ.Price: 402.80, Change: +0.40, Percent Change: +0.10
Medpace Holdings Is Maintained at Outperform by Baird
Medpace Holdings Is Maintained at Outperform by Baird
Baird Maintains Medpace(MEDP.US) With Buy Rating, Raises Target Price to $469
Baird analyst Eric Coldwell maintains $Medpace(MEDP.US)$ with a buy rating, and adjusts the target price from $454 to $469.According to TipRanks data, the analyst has a success rate of 52.2% and a
Medpace Holdings, Inc.'s (NASDAQ:MEDP) P/E Still Appears To Be Reasonable
Medpace Holdings, Inc.'s (NASDAQ:MEDP) price-to-earnings (or "P/E") ratio of 39.8x might make it look like a strong sell right now compared to the market in the United States, where around half of the
$1000 Invested In Medpace Hldgs 5 Years Ago Would Be Worth This Much Today
Medpace Hldgs (NASDAQ:MEDP) has outperformed the market over the past 5 years by 31.94% on an annualized basis producing an average annual return of 45.04%. Currently, Medpace Hldgs has a market capit
Comments
Investors expect Medpace Holdings to outperform the market, hence its high P/E ratio. Strong future growth anticipation makes investors pay more for the stock, supporting the share price.
The Price Is Right For Medpace Holdings, Inc. (NASDAQ:MEDP) 1
Medpace Holdings' robust conversion of profit to free cash flow is promising. Its underlying earnings potential may even surpass the statutory profit. Its earnings per share have seen a remarkable growth over the past three years.
1
Medpace Holdings' market sentiment remains steady, mirroring EPS growth. The stock's recent performance shows improvement, with a 90% shareholder return over the last year, surpassing the five-year TSR of 41% per year. The strong share price momentum suggests a closer look at the stock may be worthwhile.
Medpace's high P/E is backed by its forecast growth being higher than the wider market. Investors are quite confident in the company's future earnings and seem willing to pay more for the stock, suggesting a bullish outlook.
Insider selling at current price (US$274) is less worrying, but there were no purchases over the past year to boost confidence. A high level of insider ownership often implies interests of all shareholders are considered, though recent history of share sales triggers some hesitation.
Read more